findmyKOL

Gilbert Daniels, MD

Basic profile

Harvard University

ORCIDNPI
RegionBoston, MA · NortheastSpecialtyEndocrinology, Diabetes & MetabolismFocusEndocrinology/Metabolic
Last active 2019EmergingfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2019Online presenceNot yet checkedPaymentsNone reportedNIH funding1997–1997Why? →

Gilbert Daniels is an Endocrinology/Metabolic physician affiliated with Harvard University. OpenAlex indexes 229 publications with 20,301 citations (h-index 56). By OpenAlex citation count, this profile ranks in the top 10% of Endocrinology, Diabetes & Metabolism profiles in the findmyKOL directory.

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
229publications

Distinct works indexed by OpenAlex, matched via ORCID.

20,301citations

Total citations across indexed works.

56h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
1NIH grants · 1997–1997

Federally funded research awards.

View funding

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

15 Parkman St
Thyroid Associates Wac 730s
Boston, MA 021143117

Telephone

617-726-8430

Registry record last updated 8 Jan 2013.

View the NPPES registry record

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Hormonal (systemic)

    94.3%
    l-Thyroxine77.7%
    Levothyroxine Sodium81%Synthroid18%Levoxyl1%
    Part D<11 patients
    Thyroid Hormone Synthesis Inhibitor9.9%
    Methimazole100%
    Part D41 patients

    + 2 more classes in this area

  • Metabolism & gastrointestinal

    4.9%
    Corticosteroid3.1%
    Prednisone100%
    Part D<11 patients
    Vitamin D3 Analog1.8%
    Calcitriol100%
    Part D<11 patients
  • Nervous system

    0.8%
    Ergot Derivative0.8%
    Cabergoline100%
    Part D<11 patients
Where care is delivered (Part B)0% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

1 NIH research award on record, funded 19971997 per NIH RePORTER. The latest:

Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”